On ECHEMI
Home > Drugs > Tonghua Baishan Pharmaceutical Stock Co., Ltd.

Tonghua Baishan Pharmaceutical Stock Co., Ltd.

  • Founded in:

    1999-04-08
  • Country:

    China China
  • Address:

    Jilin Province Tonghua Wanwanchuan Development Zone
  • Tax NO.:

    91220501702337222J
  • Registered Funds:

    33 million yuan
  • Email:

Related Drugs
Bitong Tincture
Wild grape vine, Rhizoma Dioscoreae, deer bone glue, and processed Aconitum carmichaelii.
Name Description Content CAS NO. Registered Holders
mountain grape vine

0
DIOSCOREAE NIPPONICAE RHIZOMA

0
Deer Bone Glue

0
ACONITI KUSNEZOFFII RADIX COCTA

0
Qi-regulating and soothing tablets
Angelica sinensis, agarwood, Poria cocos, costus root, Cyperus rotundus (made with vinegar), turmeric, Curcuma zedoaria (made with vinegar), bergamot, tangerine peel, Citrus aurantium (fried), Citrus aurantium (made with vinegar), malt (fried), Citrus aurantium, Citron, Tripterygium wilfordii (made with vinegar), Salvia miltiorrhiza
Name Description Content CAS NO. Registered Holders
Wulingzhi

0
Salvia Root P.E Tanshinone IIA 20%

0
Tripterygium wilfordii (made with vinegar)

0
Citri Fructus

0
AURANTII FRUCTUS

0
Malt (roasted)

0
Green peel (vinegar)

0
Citrus aurantium (fried)

0
Citri reticulatae pericarpium

0
Angelicae Sinensis Radix

0
Citri Sarcodactylis Fructus

0
Curcuma zedoaria (made with vinegar)

0
TURMERIC 1G [R]

0
Cyperus rotundus (made with vinegar)

0
Aucklandiae Radix

0
Poria

0
Aquilariae lignum resinatum

0
Acanthopanax ginseng root and Astragalus extract
Acanthopanax senticosus, Chinese angelica, Astragalus. Auxiliary ingredients: honey, essence, sodium citrate, sodium benzoate.
Name Description Content CAS NO. Registered Holders
Acanthopanax Root-Bark Extract

0
Angelicae Sinensis Radix

0
Astragali Radix

0
Honey

8028-66-8 91
Costus oil

8023-88-9 0
Trisodium citrate dihydrate

6132-04-3 32
Sodium benzoate

532-32-1 23
Qidong Yixin Oral Liquid
Astragalus, Ophiopogon japonicus, Ginseng, Poria cocos, Rehmannia glutinosa, Tortoise shell (scalded), Purple quartz (calcined), Cassia twig, Epimedium, Honeysuckle, Salvia miltiorrhiza, Curcuma aromatica, Citrus aurantium (fried).
Name Description Content CAS NO. Registered Holders
Astragali Radix

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
Ophiopogonis Radix

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
ASIAN GINSENG

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
Poria

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
REHMANNIAE RADIX PRAEPARATA

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
Tortoise shell (perm)

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
Amethyst (calcined)

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
Cmnamomi Mmulus

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
Epimedium P.E Icariin 10%,20% HPLC

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
LONICERAE JAPONICAE FLOS

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
Salvia Root P.E Tanshinone IIA 20%

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
CURCUMAE RADIX

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
Citrus aurantium (fried)

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

More

The myocarditis model test of animals infected with Coxsackie B virus type B3 Nancy strain showed that this product has a certain inhibitory effect on the virus. The results of hemodynamics and myocardial oxygen consumption tests on anesthetized dogs showed that this product can reduce coronary resistance, increase coronary flow, and reduce myocardial oxygen consumption. The myocardial ischemia experiment induced by ligation of the coronary artery in dogs showed that this product can reduce the degree and range of myocardial ischemia and reduce the area of myocardial infarction.

0
Mestanol hydrochloride tablets
The main ingredient of this product is: mestanol hydrochloride.
Name Description Content CAS NO. Registered Holders
L-Cysteine methyl ester hydrochloride

This product is a mucolytic expectorant that has the effect of dissolving sputum because the thiol (-SH) in its molecule can break the -S-S- bond of mucin in mucus, causing the viscosity to drop rapidly, making the sputum easier to cough up.

More

This product is a mucolytic expectorant that has the effect of dissolving sputum because the thiol (-SH) in its molecule can break the -S-S- bond of mucin in mucus, causing the viscosity to drop rapidly, making the sputum easier to cough up.

18598-63-5 2
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.